<DOC>
	<DOCNO>NCT01108796</DOCNO>
	<brief_summary>This post-marketing surveillance study design supplement data efficacy tolerability Micardis® MicardisPlus® patient cardiovascular risk general practice condition . The aim study investigate effect six-month treatment Micardis® / MicardisPlus® blood pressure effect Lifestyle education tool weight reduction blood pressure control . In addition , post-marketing surveillance study provide information effect target measurement Lifestyle education tool various laboratory parameter produce treatment Micardis® MicardisPlus® unselected patient population general practice condition .</brief_summary>
	<brief_title>Additional Effect A Life Style Program Antihypertensive Treatment With Telmisartan</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients essential hypertension ( blood pressure ( BP ) high equal 140/90 mmHg high equal 130/80 mmHg case diabetic patient ) 2 . Patients hypertension treatment one antihypertensive drug Exclusion criterion : Patients exclude accord summary product characteristic ( SmPC ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>